99mTc-labeled nanocolloid drugs: development methods

Research output: Contribution to journalArticlepeer-review


The work considers the problem of obtaining nanocolloid radiopharmaceuticals (RPs) and studying their functional suitability for diagnosing sentinel lymph nodes (SLN) in cancer patients. Two principal approaches to the formation of technetium-99m-labeled particles based on inorganic and organic matrices were considered when carrying out research to develop methods for the production of nanocolloid RPs. The composition of the reagents and the conditions for obtaining nanocolloid radiopharmaceuticals were determined. The functional suitability of new RPs for scintigraphic diagnostics of sentinel lymph nodes has been studied.

Original languageEnglish
Article number14013
JournalScientific Reports
Issue number1
Publication statusPublished - 1 Dec 2020

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of '<sup>99m</sup>Tc-labeled nanocolloid drugs: development methods'. Together they form a unique fingerprint.

Cite this